KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Current Taxes (2021 - 2024)

Moderna (MRNA) has disclosed Current Taxes for 4 consecutive years, with $4.0 million as the latest value for Q3 2024.

  • Quarterly Current Taxes fell 92.86% to $4.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Sep 2024, down 92.86% year-over-year, with the annual reading at $63.0 million for FY2023, 31.25% up from the prior year.
  • Current Taxes for Q3 2024 was $4.0 million at Moderna, down from $7.0 million in the prior quarter.
  • The five-year high for Current Taxes was $1.6 billion in Q1 2022, with the low at $4.0 million in Q3 2024.
  • Average Current Taxes over 4 years is $291.6 million, with a median of $63.0 million recorded in 2023.
  • Peak annual rise in Current Taxes hit 31.25% in 2023, while the deepest fall reached 95.85% in 2023.
  • Over 4 years, Current Taxes stood at $876.0 million in 2021, then tumbled by 94.52% to $48.0 million in 2022, then surged by 31.25% to $63.0 million in 2023, then crashed by 93.65% to $4.0 million in 2024.
  • According to Business Quant data, Current Taxes over the past three periods came in at $4.0 million, $7.0 million, and $52.0 million for Q3 2024, Q2 2024, and Q1 2024 respectively.